Monkeypox can have “devastating outcomes” on severely immunocompromised patients such as those with untreated HIV, according to the US CDC.
Monkeypox can have “devastating outcomes” on severely immunocompromised patients such as those with untreated HIV, according to the US Centers for Disease Control and Prevention. New research published Wednesday in the CDC’s Morbidity and Mortality Weekly Report examined clinical case data for 57 patients hospitalized with monkeypox complications and found that 82% had an HIV infection. “Monkeypox and HIV have collided with tragic effects,” said CDC Monkeypox Incident Commander Dr.
Health care providers are urged to start monkeypox therapies, such as Tpoxx, early – even before test results and before symptoms worsen. Tpoxx, or tecovirimat, is a drug used to treat monkeypox that can be taken intravenously or as an oral pill. While not approved by the US Food and Drug Administration specifically for use against monkeypox, the CDC has made the drug available from the Strategic National Stockpile.